Revenue
No reported data
RetinalGenix Technologies Inc. (RTGN)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $83,040 | $373,271 | $524,183 | $809,255 | $747,808 | $431,557 |
| Operating expenses | $2.4M | $4.3M | $2.1M | $3.9M | $2.2M | $2.1M |
| Net income | −$2.4M | −$4.3M | −$2.1M | −$3.9M | −$2.2M | −$2.1M |
| Basic EPSper diluted share | -$0.13 | -$0.24 | -$0.12 | -$0.25 | -$0.05 | -$0.05 |
| Diluted EPSper diluted share | -$0.13 | -$0.24 | -$0.12 | -$0.25 | -$0.05 | -$0.05 |